Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the Thymus

  • Front Immunol. 2020 Jun 16:11:1216. doi: 10.3389/fimmu.2020.01216.
François Van Laethem  1 Ingrid Saba  1 Jinghua Lu  2 Abhisek Bhattacharya  1 Xuguang Tai  1 Terry I Guinter  1 Britta Engelhardt  3 Amala Alag  1 Mirelle Rojano  1 Jennifer M Ashe  1 Ken-Ichi Hanada  4 James C Yang  4 Peter D Sun  2 Alfred Singer  1
Affiliations
  • 1. Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
  • 2. Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, United States.
  • 3. Theodor Kocher Institute, Faculty of Bern, Universität Bern, Bern, Switzerland.
  • 4. Surgery Branch, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
Abstract

MHC-independent αβTCRs (TCRs) recognize conformational epitopes on native self-proteins and arise in mice lacking both MHC and CD4/CD8 coreceptor proteins. Although naturally generated in the thymus, these TCRs resemble re-engineered therapeutic chimeric antigen receptor (CAR) T cells in their specificity for MHC-independent ligands. Here we identify naturally arising MHC-independent TCRs reactive to three native self-proteins (CD48, CD102, and CD155) involved in cell adhesion. We report that naturally arising MHC-independent TCRs require high affinity TCR-ligand engagements in the thymus to signal positive selection and that high affinity positive selection generates a peripheral TCR repertoire with limited diversity and increased self-reactivity. We conclude that the affinity of TCR-ligand engagements required to signal positive selection in the thymus inversely determines the diversity and self-tolerance of the mature TCR repertoire that is selected.

Keywords
MHC restriction; MHC-independent; coreceptors; thymic selection; tolerance.
Products